|1.||Shastri, J: 1 article (10/2011)|
|2.||Jameel, S: 1 article (10/2011)|
|3.||Taneja, S: 1 article (10/2011)|
|4.||Munshi, S U: 1 article (10/2011)|
|5.||Aggarwal, R: 1 article (10/2011)|
|6.||Bhavesh, N S: 1 article (10/2011)|
|7.||Ponce, Adrian: 1 article (05/2010)|
|8.||Esplin, Taran L: 1 article (05/2010)|
|9.||Cable, Morgan L: 1 article (05/2010)|
|10.||Gray, Harry B: 1 article (05/2010)|
10/01/1987 - "Since 2-hydroxybenzoylglycine has been chemically defined to be a major drug binding inhibitor in uremia, a search for the presence of a similar compound in the sera of newborn infants was made. "
05/01/1983 - "Isolation and chemical characterization of 2-hydroxybenzoylglycine as a drug binding inhibitor in uremia."
01/01/1986 - "Protein binding of ceftriaxone: comparison of three techniques of determination and the effect of 2-hydroxybenzoylglycine, a drug-binding inhibitor in uremia."
05/01/1983 - "Average steady-state serum salicylate concentrations and salicyluric acid (SU) formation rates were measured in 4 subjects with rheumatoid arthritis. "
05/01/1984 - "Steady-state kinetics of SA (total and unbound), salicyluric acid (SUA), gentisic acid (GA), and clinical status were estimated weekly in 10 patients with rheumatoid arthritis. "
05/01/1983 - "Induction of salicyluric acid formation in rheumatoid arthritis patients treated with salicylates."
10/01/1989 - "1. The pharmacokinetics of salicylic acid (SA) and its major metabolite salicyluric acid (SU) were studied in nine patients with rheumatoid arthritis following a 900 mg oral dose of acetylsalicylic acid and during 6 weeks of chronic administration of enteric coated aspirin (3,900 mg day). "
10/01/2011 - "The main metabonomic changes found in patients with hepatitis E, but not in those with hepatitis B, included increased plasma levels of L-isoleucine, acetone, and glycerol, reduced plasma levels of glycine, and reduced urinary levels of imidazole, 3-aminoisobutanoic acid, 1-methylnicotinamide, biopterin, adenosine, 1-methylhistidine, and salicyluric acid. "
|5.||Liver Diseases (Liver Disease)
|1.||Aspirin (Acetylsalicylic Acid)
|2.||Salicylic Acid (2 Hydroxybenzoic Acid)
|3.||Glycine (Aminoacetic Acid)
|8.||Carrier Proteins (Binding Protein)